4th Quarter - Report
ALLERGAN, INC. for ALLERGAN, INC.
Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
NO SPECIFIC BILL: TAX REFORM ISSUES
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD C RENO | N/A |
Health Issues HCR
NO SPECIFIC BILL: FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDANCE ON CYCLOSPORINE
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD C RENO | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.